article · 2018
PCN232 - VARIATION IN ACCESS TO PD-1 IMMUNOTHERAPIES IN EUROPE
Over the past decade there has been significant innovation in the treatment of cancer, driven by advances in personalised medicine and immunotherapies. PD-1/...
0 citationsDOI: https://doi.org/10.1016/j.jval.2018.09.314Open accessPDF reported by metadataFull text reported by metadata